Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Naloxone Market Insights, Size, Share & Growth Forecast to 2032
The Naloxone market is mainly concerning the development, supply, and utilization of Naloxone, a drug mainly used to treat opioid poisoning. This market comprises products with trademarks and those that are lettered in various formulation forms, dispensed through hospitals, clinics, pharmacies, and emergency service providers.
IMR Group
Description
Naloxone Market Synopsis:
Naloxone Market Size Was Valued at USD 1215.1 Million in 2023, and is Projected to Reach USD 2960.3 Million by 2032, Growing at a CAGR of 10.4% From 2024-2032.
The Naloxone market is mainly concerning the development, supply, and utilization of Naloxone, a drug mainly used to treat opioid poisoning. This market comprises products with trademarks and those that are lettered in various formulation forms, dispensed through hospitals, clinics, pharmacies, and emergency service providers. Widespread use of opioids and increasing fatal overdoses spikes the demand for Naloxone. Moreover, the Market includes new forms of delivery, such as nasal sprays and injectors to enhance the practical application in the case of an emergency.
The market for Naloxone has evolved significantly in the recent past due to the ever-increasing usage of opioids globally especially in the regions in North America and the Europe. The governments and health organizations are wanting for such interventions like Naloxone so as to mitigate the availability of opioid-associated deaths. This awareness has developed multiple policy actions that increase the accessibility of Naloxone to members of the public, other healthcare workers, and other first-line responders. In addition, there is increased government funding of facilities that offer rehabilitation and more extensive advertising through public health campaigns has bolstered the marketplace as campaigns to curb the abuse of opioids and related deaths continue to ramp up.
As an antidote of opioid overdose, Naloxone has received attention not only as an emergency intervention instrument but also as the essential element of the public health plan to address the opioid crisis. Naloxone comes in many forms by the use of different formats vary depending on individual necessity and utilizing formats that allow laypersons to administer the drug by injections or nasal spray. In addition, the partnerships between the public and private entities are guaranteeing that Naloxone is delivered at free or a lower price that boosts market expansion.
Naloxone Market Trend Analysis:
Innovative Delivery Systems Transforming Accessibility
There is a significant emerging trend in the Naloxone market regarding the devise of new methods of administering the drug at the times it is needed most. Originally, only Naloxone in the injectable formulation existed, and it could only be administered by personnel with medical skills. But in recent decades there has been a rise in nose-drip formulations and small pre-filled injectors by which anyone can give the drug. New delivery methods are quickly becoming popular especially in the regions characterized by opioid overdoses because they offer a swift approach during emergencies.
It shows that such innovations are not only increasing the effectiveness of Naloxone but also it availability at places like schools, workplaces and public transport systems. In many instances, awareness campaigns are also raising awareness on how to use such devices additionally putting more people into action in case of an overdose. This trend of advanced delivery systems is likely to persist to existence as drug firms see fit to ensure that Naloxone is more convenient to use, administered, and accepted in the market.
Expansion in Developing Regions
One of the highly prospective avenues in the context of the Naloxone market is the enhancement of the Naloxone distribution in developed countries as well as the establishment of the Naloxone selling in the developing countries where illicit opioid consumption is increasingly growing. Thus, even though the opioid epidemic is most acute in North America, emerging economies of Asia, Eastern Europe and even Latin America are only starting to experience that pile. As these governments and health organizations continue looking for cost effective ways to reduce deaths resulting from overdose, there are possibilities for pharma companies to bring into the market cheaper Naloxone.
Naloxone Market Segment Analysis:
Naloxone Market is Segmented on the basis of Type, Application, End User, and Region.
By Strength, 0.02mg/ml segment is expected to dominate the market during the forecast period
The segment by strength of 0.02 mg/mL is expected to be the largest in the Naloxone market during the forecast period due to its utility and efficacy in emergency settings. Low dose opioid antagonist formulation is used extensively in hospital and clinical setting due to its safe and controlled manner in reversing the effects of opioids in patents. It has gained popularity as a result of increasing risk associated with narcotics and other opioids, which demands accurate, simple to administer Naloxone doses to be administered by medical personnel and trained individuals in risky situations. Similarly, the extension of the 0.02 mg/mL segment’s compatibility with nasal spray and injectable systems door and further extends its capabilities in the market. Moreover, as more public health efforts demand consumer accessible Nalaxone friendly forms this segment will prove highly influential from its applicability and effectiveness in overdose cessation.
By Route Of Administration, Injectables segment expected to held the largest share
The injectables segment by route of administration is expected to continue leading the Naloxone market, particularly due to the rapid and effective counteracting of the overdoses of opioids that may be crucial for saving a life. The rationale for using Injectable Naloxone is that it gets directly into the bloodstream and is ready to work almost instantly especially in cases of extreme Cases of respiratory depression due to opioids. This route of administration is favored by healthcare professionals and emergency responders for its effectiveness, and efficient time to onset. The injectables segment also has positives due to technical development in auto-injector systems, which makes it easier to be used by anyone other than a health care professional during public health driven campaigns. Therefore, injecting the drug is still crucial to managing an overdose situation and further strengthening its position in the market.
Naloxone Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
In 2023, North America is projected to be the largest market for Naloxone mainly due to the United States where opioids problem has been prevalent. If we take a general view of the existing governmental strategies concerned with the enhancement of the public accessibility over Naloxone, they include the sales of Naloxone in schools, chemist’s shops and via other community programs which have greatly enhanced the market. Especially North Americans have an estimated market share of 70 percent, thus documenting the dominating position of the region. This dominance is also backed by large funding and adverts for public health interventions to reduce the effects of the opioid epidemic.
Active Key Players in the Naloxone Market:
Adapt Pharma (Ireland)
Ampharco USA (Vietnam)
Amphastar Pharmaceuticals, Inc. (USA)
BioDelivery Sciences International (USA)
Emergent BioSolutions (USA)
Hikma Pharmaceuticals (UK)
Indivior PLC (UK)
Kaleo, Inc. (USA)
Mundipharma International Limited (UK)
Mylan N.V. (USA)
Novartis AG (Switzerland)
Pfizer, Inc. (USA)
Sandoz International GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
West-Ward Pharmaceuticals (USA)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Naloxone Market by Strength
4.1 Naloxone Market Snapshot and Growth Engine
4.2 Naloxone Market Overview
4.3 0.02mg/ml
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 0.02mg/ml: Geographic Segmentation Analysis
4.4 1mg/ml
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 1mg/ml: Geographic Segmentation Analysis
4.5 0.4mg/ml
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 0.4mg/ml: Geographic Segmentation Analysis
4.6 Others
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Others: Geographic Segmentation Analysis
Chapter 5: Naloxone Market by Route of Administration
5.1 Naloxone Market Snapshot and Growth Engine
5.2 Naloxone Market Overview
5.3 Injectables
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Injectables: Geographic Segmentation Analysis
5.4 Nasal
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Nasal: Geographic Segmentation Analysis
5.5 Oral
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Oral: Geographic Segmentation Analysis
Chapter 6: Naloxone Market by End User
6.1 Naloxone Market Snapshot and Growth Engine
6.2 Naloxone Market Overview
6.3 Hospital Pharmacies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Pharmacies: Geographic Segmentation Analysis
6.4 Retail Pharmacies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Retail Pharmacies: Geographic Segmentation Analysis
6.5 Online Pharmacies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Online Pharmacies: Geographic Segmentation Analysis
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Naloxone Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ADAPT PHARMA (IRELAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 AMPHARCO USA (VIETNAM)
7.4 AMPHASTAR PHARMACEUTICALS INC. (USA)
7.5 BIODELIVERY SCIENCES INTERNATIONAL (USA)
7.6 EMERGENT BIOSOLUTIONS (USA)
7.7 HIKMA PHARMACEUTICALS (UK)
7.8 INDIVIOR PLC (UK)
7.9 KALEO INC. (USA)
7.10 MUNDIPHARMA INTERNATIONAL LIMITED (UK)
7.11 MYLAN N.V. (USA)
7.12 NOVARTIS AG (SWITZERLAND)
7.13 PFIZER INC. (USA)
7.14 SANDOZ INTERNATIONAL GMBH (GERMANY)
7.15 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.16 WEST-WARD PHARMACEUTICALS (USA)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Naloxone Market By Region
8.1 Overview
8.2. North America Naloxone Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Strength
8.2.4.1 0.02mg/ml
8.2.4.2 1mg/ml
8.2.4.3 0.4mg/ml
8.2.4.4 Others
8.2.5 Historic and Forecasted Market Size By Route of Administration
8.2.5.1 Injectables
8.2.5.2 Nasal
8.2.5.3 Oral
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospital Pharmacies
8.2.6.2 Retail Pharmacies
8.2.6.3 Online Pharmacies
8.2.6.4 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Naloxone Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Strength
8.3.4.1 0.02mg/ml
8.3.4.2 1mg/ml
8.3.4.3 0.4mg/ml
8.3.4.4 Others
8.3.5 Historic and Forecasted Market Size By Route of Administration
8.3.5.1 Injectables
8.3.5.2 Nasal
8.3.5.3 Oral
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospital Pharmacies
8.3.6.2 Retail Pharmacies
8.3.6.3 Online Pharmacies
8.3.6.4 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Naloxone Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Strength
8.4.4.1 0.02mg/ml
8.4.4.2 1mg/ml
8.4.4.3 0.4mg/ml
8.4.4.4 Others
8.4.5 Historic and Forecasted Market Size By Route of Administration
8.4.5.1 Injectables
8.4.5.2 Nasal
8.4.5.3 Oral
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospital Pharmacies
8.4.6.2 Retail Pharmacies
8.4.6.3 Online Pharmacies
8.4.6.4 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Naloxone Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Strength
8.5.4.1 0.02mg/ml
8.5.4.2 1mg/ml
8.5.4.3 0.4mg/ml
8.5.4.4 Others
8.5.5 Historic and Forecasted Market Size By Route of Administration
8.5.5.1 Injectables
8.5.5.2 Nasal
8.5.5.3 Oral
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospital Pharmacies
8.5.6.2 Retail Pharmacies
8.5.6.3 Online Pharmacies
8.5.6.4 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Naloxone Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Strength
8.6.4.1 0.02mg/ml
8.6.4.2 1mg/ml
8.6.4.3 0.4mg/ml
8.6.4.4 Others
8.6.5 Historic and Forecasted Market Size By Route of Administration
8.6.5.1 Injectables
8.6.5.2 Nasal
8.6.5.3 Oral
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospital Pharmacies
8.6.6.2 Retail Pharmacies
8.6.6.3 Online Pharmacies
8.6.6.4 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Naloxone Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Strength
8.7.4.1 0.02mg/ml
8.7.4.2 1mg/ml
8.7.4.3 0.4mg/ml
8.7.4.4 Others
8.7.5 Historic and Forecasted Market Size By Route of Administration
8.7.5.1 Injectables
8.7.5.2 Nasal
8.7.5.3 Oral
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospital Pharmacies
8.7.6.2 Retail Pharmacies
8.7.6.3 Online Pharmacies
8.7.6.4 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Q1: What would be the forecast period in the Naloxone Market research report?
A1: The forecast period in the Naloxone Market research report is 2024-2032.
Q2: Who are the key players in the Naloxone Market?
A2: Adapt Pharma (Ireland), Ampharco USA (Vietnam), Amphastar Pharmaceuticals, Inc. (USA), BioDelivery Sciences International (USA), Emergent BioSolutions (USA), Hikma Pharmaceuticals (UK), Indivior PLC (UK), Kaleo, Inc. (USA), Mundipharma International Limited (UK), Mylan N.V. (USA), Novartis AG (Switzerland), Pfizer, Inc. (USA), Sandoz International GmbH (Germany), Teva Pharmaceutical Industries Ltd. (Israel), West-Ward Pharmaceuticals (USA), and Other Active Players.
Q3: What are the segments of the Naloxone Market?
A3: The Naloxone Market is segmented into Strength, Route Of Adminstration, End User and region. By Type, the market is categorized into 0.02mg/ml, 1mg/ml, 0.4mg/ml, Others. By Application, the market is categorized into Injectables, Nasal, Oral. By End User, the market is categorized into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Naloxone Market?
A4: The Naloxone market is mainly concerning the development, supply, and utilization of Naloxone, a drug mainly used to treat opioid poisoning. This market comprises products with trademarks and those that are lettered in various formulation forms, dispensed through hospitals, clinics, pharmacies, and emergency service providers.
Q5: How big is the Naloxone Market?
A5: Naloxone Market Size Was Valued at USD 1215.1 Million in 2023, and is Projected to Reach USD 2960.3 Million by 2032, Growing at a CAGR of 10.4% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
